The character banners for Genshin Impact 5.6 have allegedly leaked, giving players some insight into what they can expect in ...

On Thursday, the NFL announced the offseason workout program dates for all 32 teams, and with the Chicago Bears having a new ...

Opus Genetics (IRD) announced one-month clinical data from the first pediatric patient treated with its investigational gene therapy, ...

NKGen Biotech (NKGN) announced the oral presentation of updated Phase 1 clinical data from the Phase 1/2a trial evaluating troculeucel, ...

A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral ...

RXRX's CDK7 inhibitor REC-617 has demonstrated activity, but additional data from the ELUCIDATE trial in various solid tumors ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...

More new multifamily housing is planned as part of Phase 2 of the Water Tower District at Schilling Farms in Collierville.

Phase 4 saw TV shows folded into the MCU's interconnected storylines more than ever before and this has continued throughout Phase 5 and the already-confirmed Phase 6, which will wrap up with an ...

The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at ...